Research Projects
(for detailed project description please click on the Project Number)

Theme 1

Identify age-related immune system defects to develop new vaccines and supplemental therapies to enhance protection of individuals to NIAID Category A-C pathogens. (Research Projects 001, 002 & 003)

RP001   CD8 Responses in Situations of Limited T-cell Repertoire
              Michael Bevan, Ph.D., University of Washington

RP002   Broad-Based Intervention to Improve T-cell Protection in Normal and Vulnerable               Populations
              Janko Nikolich-Zugich, M.D., Ph.D., University of Arizona
              Scott Wong, Ph.D., Oregon Health & Science University

RP003    Yellow Fever Vaccination of the Elderly and the Immune Compromised
              Mark Slifka, Ph.D., Oregon Health & Science University

Theme 2

Use systems genetic, chemical and proteomics approaches to identify therapeutic targets for biodefense and emerging diseases (Research Projects 004, 005, 006, 007, 008  & 009).

RP004   Systems Pathogenomics of  Severe Respiratory Virus Infection
              Ralph Baric, Ph.D., University of North Carolina

RP005   Mechanisms of Ebola Virus Pathogenesis and Innate and Adaptive Immunity
              Yoshihiro Kawaoka, D.V.M., Ph.D., University of Wisconsin
              Michael Gale, Jr., Ph.D., University of Washington
              Ilhem Messaoudi, Ph.D., Oregon Health & Science University

RP006   Systems Biology Approaches to Viral Pathogenesis and Immunity
              Michael G. Katze, Ph.D., University of Washington

RP007   Pro- and Anti-viral Host Pathways in Flavivirus Pathogenesis
              Michael Gale, Jr., Ph.D., University of Washington
              Michael Diamond, Ph.D., Washington University St. Louis

RP008   Kinase Networks Controlling Flavivirus Replication
              Klaus Frueh, Ph.D., Oregon Health & Science University
              Jay A. Nelson, Ph.D., Oregon Health & Science University
              Hakim Djaballah, Ph.D., Memorial Sloan Kettering Cancer Center

RP009   Small Molecule Flavivirus Inhibitors
              Eric Barklis, Ph.D., Oregon Health & Science University

ARRA     A Novel Platform for Rapid Development of Anti-WNV Antibodies
              Nancy Maizels, Ph.D., University of Washington
              Munehisa Yabuki, Ph.D., University of Washington